Brian Mendelsohn

Dr. Brian Mendelsohn

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Nature Biotechnology
Verified
Journal Article
Closed access
SDSvetlana O Doronina
Svetlana O Doronina
BTBrian E Toki
Brian E Toki
MTMichael Y Torgov
Michael Y Torgov
BMBrian Mendelsohn
Brian Mendelsohn
CCCharles G Cerveny
Charles G Cerveny
PSPeter D Senter
Peter D Senter

22 December 2005 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
SDSvetlana O. Doronina
Svetlana O. Doronina
BMBrian Mendelsohn
Brian Mendelsohn
TBTim D. Bovee
Tim D. Bovee
CCCharles G. Cerveny
Charles G. Cerveny
SAStephen C. Alley
Stephen C. Alley
PSPeter D. Senter
Peter D. Senter

2 March 2009 in Organic Letters
Verified
Journal Article
Closed access
BMBrian Mendelsohn
Brian Mendelsohn
SLShelley Lee
Shelley Lee
SKSimon Kim
Simon Kim
FTFlorian Teyssier
Florian Teyssier
VAVirender S. Aulakh
Virender S. Aulakh
MCMarco A. Ciufolini
Marco A. Ciufolini

12 April 2018 in Cancer Research
Verified
Journal Article
Closed access
PDF file
HZHui Zhao
Hui Zhao
JAJohn Atkinson
John Atkinson
SGSara Gulesserian
Sara Gulesserian
ZZZhilan Zeng
Zhilan Zeng
JNJenny Nater
Jenny Nater
FDFernando Doñate
Fernando Doñate
AGS-16C3F is an antibody–drug conjugate (ADC) against ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3) containing the mcMMAF linker-payload currently in development for treatment of metastatic renal cell carcinoma. AGS-16C3F and other ADCs have been reported to cause ocular toxicity in patients by unknown mechanisms. To investigate this toxicity, we developed an in vitro assay using human corneal epithelial cells (HCEC) and show that HCECs internalized AGS-16C3F and other ADCs by macropinocytosis, causing inhibition of cell proliferation. We observed the same mechanism for target-independent internalization of AGS-16C3F in fibroblasts and human umbilical vein endothelial cells (HUVEC). Macropinocytosis-mediated intake of macromolecules is facilitated by the presence of positive charges or hydrophobic residues on the surface of the macromolecule. Modification of AGS-16C3F, either by attachment of poly-glutamate peptides, mutation of residue K16 to D on AGS-16C3F [AGS-16C3F(K16D)], or decreasing the overall hydrophobicity via attachment of polyethylene glycol moieties, significantly reduced cytotoxicity against HCECs and other primary cells. Rabbits treated with AGS-16C3F showed significant ocular toxicity, whereas those treated with AGS-16C3F(K16D) presented with less severe and delayed toxicities. Both molecules displayed similar antitumor activity in a mouse xenograft model. These findings establish a mechanism of action for target-independent toxicities of AGS-16C3F and ADCs in general, and provide methods to ameliorate these toxicities. Significance: These findings reveal a mechanism for nonreceptor-mediated toxicities of antibody drug conjugates and potential solutions to alleviate these toxicities. Cancer Res; 78(8); 2115–26. ©2018 AACR.

10 March 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
KYKei Yamada
Kei Yamada
NSNatsuki Shikida
Natsuki Shikida
KSKazutaka Shimbo
Kazutaka Shimbo
YIYuji Ito
Yuji Ito
ZKZahra Khedri
Zahra Khedri
BMBrian Mendelsohn
Brian Mendelsohn

7 June 2002 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TKToni Kline
Toni Kline
NANiels H. Andersen
Niels H. Andersen
EHEric A. Harwood
Eric A. Harwood
JBJason Bowman
Jason Bowman
AMAndre Malanda
Andre Malanda
SZShuguang Zhu
Shuguang Zhu